Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using model-system genetics for drug-based target discovery.

D J. Matthews1, J Kopczynski

  • 1Exelixis, 170 Harbor Way, South San 94083 0511, Francisco, CA, USA

Drug Discovery Today
|February 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumour thrombus consistency has no impact on survival in patients with renal cell carcinoma.

Polish journal of pathology : official journal of the Polish Society of Pathologists·2016
Same author

[Clinical and immunohistoenzymatic investigations in patients with vasomotor and perennial allergic rhinitis].

Otolaryngologia polska = The Polish otolaryngology·2005
Same author

[Stereotactic biopsy and brachytherapy in the diagnostics and treatment of brain tumors--preliminary report].

Neurologia i neurochirurgia polska·2002
Same author

[Mortality from cardiovascular diseases in patients with type 2 diabetes].

Przeglad lekarski·2001
Same author

The future of chronic diseases.

Central European journal of public health·2001
Same author

[Risk factors of the incidence of late vascular complications of diabetes].

Polskie Archiwum Medycyny Wewnetrznej·1999
Same journal

IdopNetworks: How to infer the individualized genetic architecture of genomics for precision medicine.

Drug discovery today·2026
Same journal

Organoid-AI platforms need integrated governance in drug discovery.

Drug discovery today·2026
Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026
Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
See all related articles

Medicinal chemistry combined with model-organism genetics accelerates drug target discovery. This approach identifies drug targets for effective compounds and reveals new pathways using known drug targets.

Area of Science:

  • Pharmacology
  • Genetics
  • Biochemistry

Background:

  • Drug target discovery is crucial for developing new therapeutics.
  • Understanding drug mechanisms of action is often challenging.
  • Model organisms offer powerful systems for biological investigation.

Purpose of the Study:

  • To highlight the synergistic potential of medicinal chemistry and model-organism genetics in drug target identification.
  • To illustrate how model systems can elucidate mechanisms of action for novel compounds.
  • To explore the use of known drugs to uncover new biological targets and pathways.

Main Methods:

  • Utilizing model-organism genetics to identify targets of compounds with in vivo efficacy.
  • Employing drugs with known targets to investigate biochemical pathways in model organisms.

Related Experiment Videos

  • Leveraging human genomic sequence data to expedite target discovery.

    • Main Results:

    • Demonstrated the dual utility of model systems in target identification and pathway elucidation.
    • Showcased how genetic approaches can validate drug targets.
    • Highlighted the acceleration of target discovery through integrated methodologies.

    Conclusions:

    • The integration of medicinal chemistry and model-organism genetics provides a robust framework for drug target discovery and validation.
    • Human genomic data significantly enhances the efficiency of identifying and validating new therapeutic targets.